Prompting endogenous repair of brain injury: science fiction or reality?
Epilepsy
Gene therapy
In situ lineage conversion
Mesial temporal lobe epilepsy with hippocampal sclerosis
Neurodegenerative medicine
Regenerative medicine
Journal
Molecular neurodegeneration
ISSN: 1750-1326
Titre abrégé: Mol Neurodegener
Pays: England
ID NLM: 101266600
Informations de publication
Date de publication:
31 05 2022
31 05 2022
Historique:
received:
26
01
2022
accepted:
26
04
2022
entrez:
31
5
2022
pubmed:
1
6
2022
medline:
3
6
2022
Statut:
epublish
Résumé
Drug-refractory forms of neurological diseases could find their next breakthrough therapy in non-pharmacological approaches to brain repair. Lentini et al. present the potential of in situ brain regeneration to address neurodegeneration in the epileptic brain.
Identifiants
pubmed: 35637520
doi: 10.1186/s13024-022-00539-7
pii: 10.1186/s13024-022-00539-7
pmc: PMC9153094
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
38Informations de copyright
© 2022. The Author(s).
Références
Cell Stem Cell. 2021 Dec 2;28(12):2104-2121.e10
pubmed: 34592167
Brain. 2005 Feb;128(Pt 2):395-404
pubmed: 15634733
Cell. 2020 Apr 30;181(3):590-603.e16
pubmed: 32272060
Nat Commun. 2020 Feb 27;11(1):1105
pubmed: 32107381
Prog Neurobiol. 2022 Jan;208:102198
pubmed: 34852273
Nature. 2020 Jun;582(7813):550-556
pubmed: 32581380